Systemic chemotherapy for urothelial cancer
Guru Sonpavde1, Thomas E Hutson, William R Berry
1Texas Oncology, PA, Webster, TX 77598, USA. guru.sonpavde@usoncology.com
Clinical Genitourinary Cancer
|July 25, 2006
Summary
Metastatic transitional cell carcinoma of the bladder eventually progresses despite chemotherapy. Neoadjuvant chemotherapy offers improved outcomes and bladder conservation, with future bladder cancer therapies showing promise.
Area of Science:
- Oncology
- Urothelial Carcinomas
- Cancer Chemotherapy
Background:
- Metastatic transitional cell carcinoma of the bladder (TCC) has a high response rate to first-line chemotherapy, but disease progression is nearly universal.
- Salvage therapy for advanced TCC after initial chemotherapy is largely ineffective, leaving patients with limited options outside of clinical trials.
Purpose of the Study:
- To evaluate the role of neoadjuvant chemotherapy in improving outcomes for patients with transitional cell carcinoma.
- To explore the potential of neoadjuvant chemotherapy in facilitating bladder conservation.
- To discuss the future directions for systemic therapy in bladder cancer.
Main Methods:
- Review of current treatment paradigms for metastatic transitional cell carcinoma.
- Analysis of the impact of neoadjuvant chemotherapy on long-term outcomes.
- Assessment of bladder conservation strategies in conjunction with neoadjuvant therapy.
Main Results:
- Neoadjuvant chemotherapy demonstrates potential for improving long-term outcomes in TCC.
- Neoadjuvant chemotherapy, with or without radiation, can lead to bladder conservation in patients achieving a complete pathologic response.
- Adjuvant chemotherapy lacks definitive supporting data.
Conclusions:
- Neoadjuvant chemotherapy represents a promising paradigm for advancing systemic therapy development in bladder cancer.
- The future of transitional cell carcinoma treatment is optimistic due to ongoing research into bladder cancer biology and novel targeted agents.
Related Concept Videos
01:30Urinary Tract Calculi III: Medical Management
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
01:25Urinary Tract Calculi VI: Surgical Management
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...